| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0002518> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0003253> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0004793> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0021011> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0021012> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0021034> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0162326> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0162327> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0376433> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0376434> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0376435> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0376436> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0475463> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0751719> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C0877857> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C1571590> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C3489397> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C3494190> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C3494191> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34095859_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Center for Antibody Therapeutics, Division of Infectious Diseases, Department of Medicine, University of Pittsburgh Medical School, Pittsburgh, PA, USA.\', \'Abound Bio, Pittsburgh, PA, USA.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Chen_Chuan> <https://research.tib.eu/covid-19/entity/Dimitrov_Dimiter_S> <https://research.tib.eu/covid-19/entity/Li_Wei> <https://research.tib.eu/covid-19/entity/Liu_Xianglei> <https://research.tib.eu/covid-19/entity/Sun_Zehua>
?:doi	10.1016/j.xpro.2021.100617
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.xpro.2021.100617>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_Non-U.S._Gov%27t>
?:journal	STAR protocols
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34095859>
?:pmid	<https://research.tib.eu/covid-19/entity/34095859>
?:pmid	34095859
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Protocol for constructing large size human antibody heavy chain variable domain (VH) library and selection of SARS-CoV-2 neutralizing antibody domains.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34095859>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34095859>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all